List of Tables
Table 1. Global Hepatitis A immunoglobulin Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Hepatitis A immunoglobulin Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Hepatitis A immunoglobulin Market Competitive Situation by Manufacturers in 2023
Table 4. Global Hepatitis A immunoglobulin Sales (Doses) of Key Manufacturers (2019-2024)
Table 5. Global Hepatitis A immunoglobulin Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Hepatitis A immunoglobulin Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Hepatitis A immunoglobulin Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Hepatitis A immunoglobulin Average Price (US$/Dose) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Hepatitis A immunoglobulin, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Hepatitis A immunoglobulin, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Hepatitis A immunoglobulin, Product Type & Application
Table 12. Global Key Manufacturers of Hepatitis A immunoglobulin, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Hepatitis A immunoglobulin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis A immunoglobulin as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Hepatitis A immunoglobulin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Hepatitis A immunoglobulin Sales by Region (2019-2024) & (Doses)
Table 18. Global Hepatitis A immunoglobulin Sales Market Share by Region (2019-2024)
Table 19. Global Hepatitis A immunoglobulin Sales by Region (2025-2030) & (Doses)
Table 20. Global Hepatitis A immunoglobulin Sales Market Share by Region (2025-2030)
Table 21. Global Hepatitis A immunoglobulin Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Hepatitis A immunoglobulin Revenue Market Share by Region (2019-2024)
Table 23. Global Hepatitis A immunoglobulin Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Hepatitis A immunoglobulin Revenue Market Share by Region (2025-2030)
Table 25. North America Hepatitis A immunoglobulin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Hepatitis A immunoglobulin Sales by Country (2019-2024) & (Doses)
Table 27. North America Hepatitis A immunoglobulin Sales by Country (2025-2030) & (Doses)
Table 28. North America Hepatitis A immunoglobulin Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Hepatitis A immunoglobulin Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Hepatitis A immunoglobulin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Hepatitis A immunoglobulin Sales by Country (2019-2024) & (Doses)
Table 32. Europe Hepatitis A immunoglobulin Sales by Country (2025-2030) & (Doses)
Table 33. Europe Hepatitis A immunoglobulin Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Hepatitis A immunoglobulin Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Hepatitis A immunoglobulin Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Hepatitis A immunoglobulin Sales by Region (2019-2024) & (Doses)
Table 37. Asia Pacific Hepatitis A immunoglobulin Sales by Region (2025-2030) & (Doses)
Table 38. Asia Pacific Hepatitis A immunoglobulin Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Hepatitis A immunoglobulin Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Hepatitis A immunoglobulin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Hepatitis A immunoglobulin Sales by Country (2019-2024) & (Doses)
Table 42. Latin America Hepatitis A immunoglobulin Sales by Country (2025-2030) & (Doses)
Table 43. Latin America Hepatitis A immunoglobulin Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Hepatitis A immunoglobulin Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Hepatitis A immunoglobulin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Hepatitis A immunoglobulin Sales by Country (2019-2024) & (Doses)
Table 47. Middle East & Africa Hepatitis A immunoglobulin Sales by Country (2025-2030) & (Doses)
Table 48. Middle East & Africa Hepatitis A immunoglobulin Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Hepatitis A immunoglobulin Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Hepatitis A immunoglobulin Sales (Doses) by Type (2019-2024)
Table 51. Global Hepatitis A immunoglobulin Sales (Doses) by Type (2025-2030)
Table 52. Global Hepatitis A immunoglobulin Sales Market Share by Type (2019-2024)
Table 53. Global Hepatitis A immunoglobulin Sales Market Share by Type (2025-2030)
Table 54. Global Hepatitis A immunoglobulin Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Hepatitis A immunoglobulin Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Hepatitis A immunoglobulin Revenue Market Share by Type (2019-2024)
Table 57. Global Hepatitis A immunoglobulin Revenue Market Share by Type (2025-2030)
Table 58. Global Hepatitis A immunoglobulin Price (US$/Dose) by Type (2019-2024)
Table 59. Global Hepatitis A immunoglobulin Price (US$/Dose) by Type (2025-2030)
Table 60. Global Hepatitis A immunoglobulin Sales (Doses) by Application (2019-2024)
Table 61. Global Hepatitis A immunoglobulin Sales (Doses) by Application (2025-2030)
Table 62. Global Hepatitis A immunoglobulin Sales Market Share by Application (2019-2024)
Table 63. Global Hepatitis A immunoglobulin Sales Market Share by Application (2025-2030)
Table 64. Global Hepatitis A immunoglobulin Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Hepatitis A immunoglobulin Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Hepatitis A immunoglobulin Revenue Market Share by Application (2019-2024)
Table 67. Global Hepatitis A immunoglobulin Revenue Market Share by Application (2025-2030)
Table 68. Global Hepatitis A immunoglobulin Price (US$/Dose) by Application (2019-2024)
Table 69. Global Hepatitis A immunoglobulin Price (US$/Dose) by Application (2025-2030)
Table 70. CSL Behring Corporation Information
Table 71. CSL Behring Description and Business Overview
Table 72. CSL Behring Hepatitis A immunoglobulin Sales (Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 73. CSL Behring Hepatitis A immunoglobulin Product
Table 74. CSL Behring Recent Developments/Updates
Table 75. AIM Vaccine Corporation Information
Table 76. AIM Vaccine Description and Business Overview
Table 77. AIM Vaccine Hepatitis A immunoglobulin Sales (Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 78. AIM Vaccine Hepatitis A immunoglobulin Product
Table 79. AIM Vaccine Recent Developments/Updates
Table 80. Sinovac Biotech Corporation Information
Table 81. Sinovac Biotech Description and Business Overview
Table 82. Sinovac Biotech Hepatitis A immunoglobulin Sales (Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 83. Sinovac Biotech Hepatitis A immunoglobulin Product
Table 84. Sinovac Biotech Recent Developments/Updates
Table 85. Pukang Biotechnology Corporation Information
Table 86. Pukang Biotechnology Description and Business Overview
Table 87. Pukang Biotechnology Hepatitis A immunoglobulin Sales (Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 88. Pukang Biotechnology Hepatitis A immunoglobulin Product
Table 89. Pukang Biotechnology Recent Developments/Updates
Table 90. Zhifei Biological Products Corporation Information
Table 91. Zhifei Biological Products Description and Business Overview
Table 92. Zhifei Biological Products Hepatitis A immunoglobulin Sales (Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 93. Zhifei Biological Products Hepatitis A immunoglobulin Product
Table 94. Zhifei Biological Products Recent Developments/Updates
Table 95. Changchun Lnstitute Of Biological Products Corporation Information
Table 96. Changchun Lnstitute Of Biological Products Description and Business Overview
Table 97. Changchun Lnstitute Of Biological Products Hepatitis A immunoglobulin Sales (Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 98. Changchun Lnstitute Of Biological Products Hepatitis A immunoglobulin Product
Table 99. Changchun Lnstitute Of Biological Products Recent Developments/Updates
Table 100. Native Antigen Corporation Information
Table 101. Native Antigen Description and Business Overview
Table 102. Native Antigen Hepatitis A immunoglobulin Sales (Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 103. Native Antigen Hepatitis A immunoglobulin Product
Table 104. Native Antigen Recent Developments/Updates
Table 105. GSK Corporation Information
Table 106. GSK Description and Business Overview
Table 107. GSK Hepatitis A immunoglobulin Sales (Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 108. GSK Hepatitis A immunoglobulin Product
Table 109. GSK Recent Developments/Updates
Table 110. Merck Corporation Information
Table 111. Merck Description and Business Overview
Table 112. Merck Hepatitis A immunoglobulin Sales (Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 113. Merck Hepatitis A immunoglobulin Product
Table 114. Merck Recent Developments/Updates
Table 115. Sanofi Corporation Information
Table 116. Sanofi Description and Business Overview
Table 117. Sanofi Hepatitis A immunoglobulin Sales (Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 118. Sanofi Hepatitis A immunoglobulin Product
Table 119. Sanofi Recent Developments/Updates
Table 120. Dr. Reddy's Laboratories Corporation Information
Table 121. Dr. Reddy's Laboratories Description and Business Overview
Table 122. Dr. Reddy's Laboratories Hepatitis A immunoglobulin Sales (Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 123. Dr. Reddy's Laboratories Hepatitis A immunoglobulin Product
Table 124. Dr. Reddy's Laboratories Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Hepatitis A immunoglobulin Distributors List
Table 128. Hepatitis A immunoglobulin Customers List
Table 129. Hepatitis A immunoglobulin Market Trends
Table 130. Hepatitis A immunoglobulin Market Drivers
Table 131. Hepatitis A immunoglobulin Market Challenges
Table 132. Hepatitis A immunoglobulin Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Hepatitis A immunoglobulin
Figure 2. Global Hepatitis A immunoglobulin Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Hepatitis A immunoglobulin Market Share by Type in 2023 & 2030
Figure 4. Inactivated Product Picture
Figure 5. Attenuated Product Picture
Figure 6. Global Hepatitis A immunoglobulin Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Hepatitis A immunoglobulin Market Share by Application in 2023 & 2030
Figure 8. Hospital
Figure 9. Pharmacy
Figure 10. Other
Figure 11. Global Hepatitis A immunoglobulin Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Hepatitis A immunoglobulin Market Size (2019-2030) & (US$ Million)
Figure 13. Global Hepatitis A immunoglobulin Sales (2019-2030) & (Doses)
Figure 14. Global Hepatitis A immunoglobulin Average Price (US$/Dose) & (2019-2030)
Figure 15. Hepatitis A immunoglobulin Report Years Considered
Figure 16. Hepatitis A immunoglobulin Sales Share by Manufacturers in 2023
Figure 17. Global Hepatitis A immunoglobulin Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Hepatitis A immunoglobulin Players: Market Share by Revenue in 2023
Figure 19. Hepatitis A immunoglobulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Hepatitis A immunoglobulin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Hepatitis A immunoglobulin Sales Market Share by Country (2019-2030)
Figure 22. North America Hepatitis A immunoglobulin Revenue Market Share by Country (2019-2030)
Figure 23. United States Hepatitis A immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Hepatitis A immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Hepatitis A immunoglobulin Sales Market Share by Country (2019-2030)
Figure 26. Europe Hepatitis A immunoglobulin Revenue Market Share by Country (2019-2030)
Figure 27. Germany Hepatitis A immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Hepatitis A immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Hepatitis A immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Hepatitis A immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Hepatitis A immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Hepatitis A immunoglobulin Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Hepatitis A immunoglobulin Revenue Market Share by Region (2019-2030)
Figure 34. China Hepatitis A immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Hepatitis A immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Hepatitis A immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Hepatitis A immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Hepatitis A immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Hepatitis A immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Hepatitis A immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Latin America Hepatitis A immunoglobulin Sales Market Share by Country (2019-2030)
Figure 42. Latin America Hepatitis A immunoglobulin Revenue Market Share by Country (2019-2030)
Figure 43. Mexico Hepatitis A immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Brazil Hepatitis A immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Argentina Hepatitis A immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Hepatitis A immunoglobulin Sales Market Share by Country (2019-2030)
Figure 47. Middle East & Africa Hepatitis A immunoglobulin Revenue Market Share by Country (2019-2030)
Figure 48. Turkey Hepatitis A immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Hepatitis A immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. UAE Hepatitis A immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Global Sales Market Share of Hepatitis A immunoglobulin by Type (2019-2030)
Figure 52. Global Revenue Market Share of Hepatitis A immunoglobulin by Type (2019-2030)
Figure 53. Global Hepatitis A immunoglobulin Price (US$/Dose) by Type (2019-2030)
Figure 54. Global Sales Market Share of Hepatitis A immunoglobulin by Application (2019-2030)
Figure 55. Global Revenue Market Share of Hepatitis A immunoglobulin by Application (2019-2030)
Figure 56. Global Hepatitis A immunoglobulin Price (US$/Dose) by Application (2019-2030)
Figure 57. Hepatitis A immunoglobulin Value Chain
Figure 58. Hepatitis A immunoglobulin Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Distributors Profiles
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed